Publications by authors named "Inge Hermens"

Claim this Profile
P
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody-Drug Conjugate.
Patrick G Groothuis, Daniëlle C H Jacobs, Inge A T Hermens, Désirée Damming, Kim Berentsen

Mol Cancer Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species-independent stimulation of osteogenic differentiation induced by osteoclasts.
Yang Zhang, Marjolein Polman, Abdullah Faqeer Mohammad, Inge Hermens, Zhumei Zhuang

Biochem Biophys Res Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically applicable CD34-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.
Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, Denise Vodegel, Inge Hermens

Cancer Immunol Immunother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis